Company / EPS (Basic)
Stoke Therapeutics, Inc. EPS (Basic) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$1.65
FY2025
5-year range
-$2.60 / -$1.65
FY2021-FY2025
Trend
+30.7%
vs FY2024
Sector context
#116 of 208
Health Care
What the data says
At $-1.65, Stoke Therapeutics, Inc.'s eps (basic) ranks #116 of 208 in the Health Care sector. Improved from $-2.60 to $-1.65 over the past 2 years.
Based on SEC 10-K filings.
-1.65 in FY2025.
Improved from $-2.60 to $-1.65 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#116 of 208 in Health CareTop 56% of 208This company -$1.65 Sector average -$0.87
▼
-89.5% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 30.7% year-over-year.
- Ranks #116 out of 208 companies in the Health Care sector.
- Lowest eps (basic) in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.65 | +30.7% |
| FY2024 | -$2.38 | +8.5% |
| FY2023 | -$2.60 | -11.1% |
| FY2022 | -$2.34 | +0.0% |
| FY2021 | -$2.34 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026